Lastly, the complexity of the tumor microenvironment and its potential influence on FGL1 and IMPDH1 regulation necessitate additional investigation to fully comprehend the interplay between these molecules and the tumor immune response. The gene discussed is IMPDH1; the disease is neoplasm.